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Background. Tubal molar pregnancy is extremely rare, with no more than 200 cases reported in the literature. The incidence is
approximated at 1.5 per 1,000,000 pregnancies. Case. We report the case of a 22-year-old woman with an overall initial stable
clinical presentation who was noted to have a ruptured ectopic pregnancy. She was surgically treated, and pathology revealed
partial hydatidiform molar ectopic pregnancy. At the time of surgical intervention, the treating physicians had not considered
molar ectopic pregnancy within the diﬀerential diagnosis, since this is a very rare presentation. Once the pathology was
discovered, the patient was contacted to be scheduled for close follow-up and counseling to reduce progression to
choriocarcinomas. Conclusion. This case report highlights the importance of sending, reviewing, and following up on
pathologic specimens for all patients undergoing surgical intervention for presumed ectopic pregnancy and ensuring that
appropriate follow-up is in place for those patients.

1. Introduction

2. Case

The incidence of ectopic pregnancy in the United States has
been approximated at 20 per 1000 pregnancies [1]. The incidence of partial or complete molar pregnancy is 1 in 1000 [2,
3]. The incidence of having both an ectopic pregnancy that is
also a molar pregnancy is extremely rare. In fact, there are
approximately 200 case reports for tubal molar pregnancies
reported in the literature with an incidence estimated to be
1.5 per 1,000,000 pregnancies [4]. The majority of these
reports have shown a good prognosis following laparoscopic
salpingectomy [5–9]. The follow-up diﬀers after a normal
ectopic pregnancy compared to a molar ectopic pregnancy
[5–9]. That is mainly since molar pregnancies, if left
untreated, have the potential to become persistent gestational trophoblastic disease and ultimately lead to malignancy and adverse outcomes. In this report, we present the
case of a 22-year-old pregnant woman who presented to
the emergency department with mild abdominal pain and
was subsequently diagnosed with an ectopic partial hydatidiform molar pregnancy.

The patient was a 22-year-old, gravida 2, para 1001 who presented to the emergency department with abdominal pain.
Her pain had started the previous day, but she attributed it
to food poisoning at that time, so she ignored it. At the start
of the abdominal pain, the patient reported having nausea
and vomiting, but upon presentation to the emergency
department, the nausea and vomiting had resolved. She continued to have mild, intermittent abdominal pain similar to
menstrual cramps. She also reported having vaginal bleeding
similar to menstrual bleeding, and that she had been on her
menstrual cycle for the past week. She was tolerating a regular diet and was able to ambulate without diﬃculties. She
reported no associated fever, chills, shortness of breath, or
chest pain.
The patient indicated that she did not have any signiﬁcant past medical history and was not on any medications.
Her gynecological history showed past infections with Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria
gonorrhoeae, and she tested positive for all 3 pathogens on
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Figure 1: Transvaginal ultrasound of right adnexa. RT: right; TRANS: transverse.

(a)

(b)

Figure 2: (a) Low power image of a partial mole shows an admixture of normal-appearing and enlarged hydropic villi scalloped borders. (b)
High power image shows nucleated red blood cells (arrow) ((a) original magniﬁcation ×100; (b) original magniﬁcation ×400, hematoxylin
and eosin (H&E) stain).

this emergency department presentation. Her exam revealed
minimal vaginal bleeding and was remarkable for right
adnexal tenderness. Bedside ultrasound showed free ﬂuid
in the right pelvic region, and the ovaries were not visualized.
She had stable vital signs and mild leukocytosis with white
blood cell count of 15.8 K/uL and platelets of 458 K/uL.
Hemoglobin levels were within reference range at 11.6 g/dL.
Her β-hCG was 23,833 mIU/mL. Rh immunoglobulin was
not indicated due to the patient’s positive Rh status. Given
her overall stable clinical status, we awaited oﬃcial ultrasound before proceeding with treatment. In the meantime,
the patient was given 2 g metronidazole, 1 g azithromycin,
and 500 mg ceftriaxone for treatment of the sexually transmitted infections. The oﬃcial ultrasound showed a normal
left ovary, no intrauterine pregnancy, a possible right ovary,
and complex ﬂuid within the right adnexa with an echogenic
structure measuring 1:16 × 1:20 × 1:1 cm with circumferential color Doppler ﬂow imaging, consistent with the “ring of
ﬁre” sign (Figure 1). The ﬁndings were concerning for a ruptured right ectopic pregnancy. Subsequently, she was prepared for a diagnostic laparoscopy, removal of the ectopic

pregnancy, possible salpingectomy, possible oophorectomy,
possible laparotomy, and all other indicated procedures.
The procedure was uncomplicated and revealed 100 mL
of hemoperitoneum upon entry. A 3 cm right tubal ectopic
pregnancy with evidence of rupture was noted. The patient’s
bowel and right adnexa were densely adherent to posterior
cul-de-sac. The right and left ovaries were buried beneath
adhesions and not identiﬁed. The left tube was normal
appearing but with some adhesions to the left pelvic side
wall. Resection of the right fallopian tube with the ectopic
pregnancy was performed in a standard fashion by using
bipolar energy device to cut and coagulate along the antimesenteric edge of the fallopian tube beneath the portion containing the ectopic and transecting at the cornual end, and
the sample was sent to pathology for analysis. The pathology
results showed histologic features consistent with partial
hydatidiform mole (Figure 2). Molecular studies for gestational disease proﬁle subsequently showed chorionic villi tissue genetically identical to maternal tissue in one set alleles
and diﬀerent in two sets of paternal alleles consistent with
a partial mole genotype (Figure 3). The patient was
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Figure 3: Genetic proﬁles of a dispermic partial hydatidiform mole
by multiplex PCR assay. Dispermic paternal alleles (with
homozygous paternal alleles in duplicate quantity in D8S1179
locus) shown, in addition to the presence of one maternal allele.
Normal biallelic proﬁles seen in the (b) maternal endometrium.

contacted multiple times, but she did not respond via telephone and was lost to follow-up until around 2 months
after her procedure. She was seen by the gynecologic
oncology service team, and she reported having no symptoms at that visit. She had a regular menstrual cycle in the
interim. The care team plan was to perform serial β-hCG
levels weekly until 3 successive β-hCG levels are negative.
The patient had a repeat β-hCG, which was <10 mIU/mL.
She was counseled on contraception and on following up
with a gynecologist.

3. Discussion
Hydatidiform moles are abnormal gestations resulting from
abnormal fertilization and are subclassiﬁed into either partial molar or complete molar pregnancies [10, 11]. The type
of molar pregnancy is dependent on morphology, pathology,
and genetic diﬀerences. Complete molar pregnancies generally carry the paternal genomic origin, 46 XX, and are due to
the fertilization of an empty ovum by 1 or occasionally 2
sperms [12]. In contrast, partial moles arise from dispermic
fertilization of a haploid ovum, resulting in a triploid
genome: 69 XXX, 69XYY, or 69 XXY [13].
Pathology is the gold standard to diagnose tubal ectopic
pregnancies [14]. The majority of the tubal molar pregnancies are managed surgically and are diagnosed incidentally
via histopathology. Ectopic pregnancies that have been managed medically with methotrexate may have a small number
of unrecognized tubal molar pregnancies. Some studies have
suggested that ectopic molar pregnancies are at times over

diagnosed because of improper diﬀerentiation from nonmolar hydropic pregnancies [15]. Molar pregnancies are
characterized by hydropic changes aﬀecting some or all of
the placental villi and are accompanied by circumferential
proliferation of trophoblasts [9]. It is important to diﬀerentiate molar from nonmolar hydropic pregnancies, as the
former have the potential to cause persistent trophoblastic
disease [9].
The clinical presentation of patients with ectopic molar
pregnancies is generally no diﬀerent than presentation for
traditional tubal pregnancies, which includes abdominal
pain and vaginal bleeding. This makes the clinical diagnosis
for the two conditions indistinguishable and more challenging. The level of β-hCG is not useful in making the distinction either [16]. Additionally, the histologic discrimination
between molar pregnancies versus hydropic abortion can
be a challenge for pathologists. Sebire et al. reported on the
overdiagnosis of ectopic molar pregnancies, where only a
small percentage of surgical specimens were actually conﬁrmed as ectopic molar pregnancies by expert gynecological
pathologists [17]. It is thus critical to complement the clinical and histological features with ploidy evaluation via DNA
ﬂow cytometric analysis [9, 15]. It is worth noting, though,
that after histological diagnosis, molecular techniques can
distinguish partial from complete mole, but they cannot help
to distinguish complete mole from hydropic abortion 15, 18.
In our case, following the histopathology of the patient’s
specimen, molecular studies for gestational disease proﬁle
were performed to show the allelic distribution and conﬁrm
the partial molar pregnancy diagnosis. The hematoxylin and
eosin stain slide was examined, and fetal and maternal DNA
was enriched by microdissection for polymerase chain reaction analysis.
The timely diagnosis of molar pregnancy (whether complete or partial) is crucial, as such pregnancies have the
potential to cause persistent gestational trophoblastic disease
[19] which has the potential to evolve into malignancy and
may ultimately lead to adverse outcomes if left untreated
[20]. Persistent gestational trophoblastic neoplasia can occur
in about 15% to 20% of complete molar pregnancies and 1%
to 6% of partial molar pregnancies [20, 21]. Due to such risk
of malignancy, after the diagnosis of molar pregnancy,
patients are normally followed with weekly quantitative
β-hCG titers until 3 successive β-hCG levels are negative.
They are then advised to avoid pregnancy for 6 months and
are counseled on appropriate contraception options [21, 22].
Our case report emphasizes the importance of histological examination of the products of conception and tissue
diagnosis after surgical management for ectopic pregnancies.
While this phenomenon is rare, it is important to keep in
mind the possibility of a hydatidiform mole in the extrauterine cavity with an ectopic pregnancy presentation. Also,
performing molecular studies to diﬀerentiate molar from
nonmolar hydropic abortions is critical, as proper management diﬀers between the two. Lastly, it is also critical to continue proper follow-up with appropriate counseling, serial
β-hCG assessment, and appropriate contraception planning
to ensure that such incidents of molar ectopic pregnancies
do not progress to choriocarcinomas.
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